1) Yac-1 cell
Yac-1细胞
1.
001) enhanced the killing activity of NK cells towards Yac-1 cells in vitro in a dose-dependent manner.
02×104Da;紫外光谱分析表明PS在260 nm处可见明显吸收峰;红外光谱分析表明,PS新出现的在1250 cm-1和810 cm-1处的吸收峰为硫酸酯化的特征峰;13C-NMR谱表明PS单糖残基上3个自由羟基均发生取代反应;PS显著提高NK细胞杀伤Yac-1细胞的活性(P<0。
2) Tumor cell Yac-I
Yac?I细胞
3) Yac-Ⅰ tumor cells
肿瘤细胞Yac-Ⅰ
4) K_(562)
yac-1
1.
Investigated the inhibition effects of lanthanum chloride and cerium chloride in yac-1 and K_(562) of tumor cells.
观察氯化镧和氯化铈对yac-1和K562细胞的作用特点,以探索其对肿瘤细胞是否具有抑制作用。
5) PANC-1 cell
PANC-1细胞
1.
Objective: To study the specific inhibition effect of short interfering RNAs(siRNA) on the mutant K-ras gene expression in PANC-1 cells.
1-K-rasv12,转染PANC-1细胞后应用RT-PCR及Westernblot检测突变型K-ras基因mRNA及蛋白质表达变化;噻唑蓝(MTT)测定细胞生长曲线;流式细胞仪测定细胞凋亡率。
2.
Objective: To access the importance of membrane cytoskeletal crosslinker ezrin for the progression of pancreatic adenocarcinoma by detecting its expression in tumor tissues, and further elucidate the anti-tumor mechanism of baicalein by investigating the effect of baicalein on ezrin expression and its relation to PANC-1 cells proliferation, invasiveness and migration.
并通过观察黄芩素对PANC-1细胞Ezrin表达的影响,探讨黄芩素抗肿瘤作用的可能机制。
3.
Methods: PANC-1 cells were exposed to 10, 20, 40 and 80 μmol / L ginsenoside Rg3 for 24 h.
方法:用浓度为0、10、20、40和80μmol/L的人参皂苷Rg3处理PANC-1细胞24h后,用四甲基偶氮唑盐(MTT)法检测人参皂苷Rg3对PANC-1细胞增殖的抑制作用;用倒置显微镜和流式细胞术观察人参皂苷Rg3对PANC-1细胞凋亡的诱导作用;用Western blot法检测经不同浓度人参皂苷Rg3处理后的PANC-1细胞中pim-3、Bad、pBad(Ser112)和pBad(Ser136)的表达;定向克隆Pim-3的发夹状寡核苷酸(shor thairpin RNA,shRNA)到真核表达载体形成重组质粒pSilencer 3。
6) THP-1 cell
THP-1细胞
1.
Comparative proteomics study of the THP-1 cells engulfing Coxiella burnetti;
THP-1细胞吞噬贝氏柯克斯体后的比较蛋白质组学研究
2.
Effects of PMA on CD147 expression in cultured supernatants of in vitro cultured THP-1 cells and on monocytes of RA patients;
PMA对THP-1细胞和RA患者单核细胞及培养上清中CD147表达的影响
3.
Study on apoptosis of THP-1 cells induced by Mycobacterium tuberculosis 19 kDa lipoprotein;
结核分枝杆菌19 kDa脂蛋白诱导THP-1细胞凋亡的研究
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条